大便潜血试验市场规模、份额及成长分析（按检测类型、最终用户和地区）- 产业预测，2025 年至 2032 年

2023 年全球大便潜血试验市场规模价值 1,925.7 亿美元，预计将从 2024 年的 2068.2 亿美元成长到 2032 年的 3,661.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.4%。

全球大便潜血试验市场对于检测粪便样本中的隐藏血液至关重要，并且是早期结肠癌诊断和监测各种胃肠道疾病的关键方法。大肠直肠癌发生率的上升、政府对筛检的支持、医疗保健基础设施的改善以及创新检测技术的采用是推动市场成长的一些因素。然而，认识的差距和高成本对扩张构成了挑战。机会包括直接面向消费者的检测选项的兴起，以及家庭免疫检测设备的线上可用性。市场按产品类型分类，例如癒创木脂FOB测试和免疫学FOB测试，并为各种最终用户提供服务，包括各个地区的医院和检测机构，主要在北美和欧洲。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

大便潜血试验市场规模（依检测类型及复合年增长率） （2025-2032）

• 市场概况
• 癒创木脂 FOB粪便检验
• 免疫FOB凝集试验
• 横向流动免疫萤光检测
• 免疫 FOB ELISA 检测

大便潜血试验市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 大肠直肠癌
• 消化道出血
• 贫血
• 其他的

大便潜血试验市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊断中心
• 其他的

大便潜血试验市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Quidel Corporation（United States）
• Wondfo（China）
• Siemens Healthineers（Germany）
• Eiken Chemical Co., Ltd.（Japan）
• Biohit Oyj（Finland）
• Becton, Dickinson and Company（BD）（United States）
• Trinity Biotech（Ireland）
• Meridian Bioscience（United States）
• Beckman Coulter（United States）
• Inova Diagnostics（United States）
• Bio-Rad Laboratories（United States）
• Abbott Laboratories（United States）
• Roche Diagnostics（Switzerland）
• Sysmex Corporation（Japan）
• US Diagnostics（United States）
• Sekisui Diagnostics（United States）
• FUJIFILM Wako Pure Chemical Corporation（Japan）
• Helena Laboratories（United States）
• Exact Sciences Corp.（United States）

结论和建议

Global Fecal Occult Testing Market size was valued at USD 192.57 billion in 2023 and is poised to grow from USD 206.82 billion in 2024 to USD 366.12 billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, serving as a key method for early colon cancer diagnosis and monitoring various gastrointestinal conditions. Market growth is fueled by increasing rates of colorectal cancer, supportive government initiatives for screening, improvements in medical infrastructure, and the adoption of innovative testing techniques. However, awareness gaps and high costs pose challenges to expansion. Opportunities arise from the rise of direct-to-consumer testing options and the availability of at-home immunological test devices online. The market is categorized by product types, including guaiac FOB tests and immuno-FOB tests, and serves diverse end users such as hospitals and laboratories across regions, notably North America and Europe.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and Region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by rising public awareness campaigns and healthcare initiatives that emphasize the necessity of colorectal cancer screening. These efforts have heightened understanding among both the general public and healthcare professionals regarding the critical role of regular screening in early detection. Additionally, government-supported screening programs and established guidelines advocating for routine fecal occult blood testing in specific age demographics are further propelling the demand for these essential tests. As awareness continues to grow, more individuals are likely to participate in screening, thereby driving market expansion and fostering early diagnosis and treatment of colorectal cancer.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant restraints due to the potential for false positive and false negative results, which can lead to diagnostic inaccuracies that affect patient care. False positives may result in unnecessary follow-up tests or procedures, causing patient anxiety and increased healthcare costs. On the other hand, false negatives may lead to overlooked diagnoses, delaying vital treatments. It is essential to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure the preservation of trust in their diagnostic capacity, ultimately impacting the market's growth and acceptance among healthcare practitioners and patients alike.

Market Trends of the Global Fecal Occult Testing Market

The global fecal occult testing market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid and convenient diagnostic solutions. These tests, optimized for primary care settings and community health clinics, particularly enhance accessibility in remote and underserved areas lacking laboratory facilities. The focus is on developing user-friendly, cost-effective point-of-care tests that enable broader screening opportunities and improve early detection rates of gastrointestinal diseases. This trend is expected to expand the market further, as healthcare providers increasingly embrace technologies that facilitate timely patient care and enhance health outcomes in resource-constrained environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Guaiac FOB stool test
• Immuno-FOB agglutination test
• Lateral flow immuno-FOB test
• Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Colorectal Cancer
• Gastrointestinal Bleeding
• Anemia
• Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic centers
• Others

Global Fecal Occult Testing Market Size & CAGR (2025-2032)

• North America (Test Type, Application, End-use)
  • US
  • Canada
• Europe (Test Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Quidel Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eiken Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• US Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations